As the clinical use of GLP-1 receptor agonists (RA) expands beyond diabetes and obesity, clinicians must balance emerging cardiometabolic and organ-specific benefits with the challenges of persistent...
In adults with type 1 diabetes and obesity using automated insulin delivery, once-weekly semaglutide significantly improved time in range, lowered HbA1c, and reduced body weight by nearly 9 kg compared with...
Large-scale evidence shows perioperative dexamethasone reduces infection risk and shortens hospital stay in patients with diabetes undergoing joint arthroplasty, though hyperglycemia remains a concern.
...
In a nationally representative cohort, adolescents and young adults with optimal cardiovascular health later had lower risks of gestational diabetes and hypertensive disorders of pregnancy than peers with...
A recent study found that daily supplementation with myo-inositol during pregnancy did not reduce the risk of gestational diabetes, preeclampsia, or preterm birth in individuals with polycystic ovary...
In the phase 3 QWINT-1 trial, efsitora achieved noninferior reductions in glycated hemoglobin compared with once-daily insulin glargine over 52 weeks, with similar fasting glucose outcomes.
A one-time intraoperative dose of dexamethasone for postoperative nausea and vomiting (PONV) prophylaxis does not increase the risk of surgical site infections in patients with diabetes mellitus, according...
A new analysis of national inpatient data reveals that women with both diabetes and polycystic ovary syndrome (PCOS) experience similar hospital outcomes to those without PCOS but face a significantly lower...
A retrospective cohort study highlights the potential of GLP-1 receptor agonists to reduce BMI and support glycemic control in adolescents and young adults with type 1 diabetes and obesity without...
Anuradha Krishnan, BA, research analyst at dQ&A, previews her presentation at the 2025 American Diabetes Association Scientific Sessions, sharing findings from a multi-country survey examining how...
